The 7 analysts offering 12-month price forecasts for Guardant Health Inc have a median target of 110.00, with a high estimate of 130.00 and a low estimate of 90.00. The median estimate represents a +13.58% increase from the last price of 96.85.
The current consensus among 8 polled investment analysts is to Buy stock in Guardant Health Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.37
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.